+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Immunologically defined subclasses of the protein kinase CK2 beta-subunit in prostate carcinoma cell lines

Immunologically defined subclasses of the protein kinase CK2 beta-subunit in prostate carcinoma cell lines

Molecular and Cellular Biochemistry 274(1-2): 181-187

Both, the activity as well as the expression of protein kinase CK2 is enhanced in various cancer types and in established tumour cell lines. This phenomenon is not due to an increase in the CK2 message but rather to posttranscriptional and posttranslational mechanisms. In order to get an insight into these posttranslational modifications we analyzed CK2 in prostate cancer cell lines, which differ by their hormone-sensitivity.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 012181084

Download citation: RISBibTeXText

PMID: 16335537

Related references

Immunologically defined subclasses of the growth suppressor protein p53 detected with antibodies in sera from tumor patients. International Journal of Oncology 3(4): 741-747, 1993

Tyrosine protein kinase activity of human hyperplastic prostate and carcinoma cell lines PC3 and DU145. Cancer Research 49(17): 4818-4823, 1989

Mitogen-activated protein kinase kinase 4/c-Jun NH2-terminal kinase kinase 1 protein expression is subject to translational regulation in prostate cancer cell lines. Molecular Cancer Research 6(3): 501-508, 2008

Alterations in the expression of the cell cycle regulatory protein cyclin kinase subunit 1 in colorectal carcinoma - Relation to p27Kip1 and its ubiquitin ligase subunit, S phase kinase protein 2. Cancer 100(8): 1615-1621, 2004

Overexpression of RII beta regulatory subunit of protein kinase A in human colon carcinoma cell induces growth arrest and phenotypic changes that are abolished by site-directed mutation of RII beta. European Journal of Biochemistry 235(3): 486-494, 1996

Activation of p38 and c-Jun NH2-terminal kinase mitogen-activated protein kinases in human prostate carcinoma cell lines with different metastatic potentials. Zhonghua Bing Li Xue Za Zhi 30(3): 194-197, 2001

Identification of protein kinase C as an intermediate in Na,K-ATPase beta-subunit mediated lamellipodia formation and suppression of cell motility in carcinoma cells. Cellular and Molecular Biology 52(8): 41-47, 2006

Association of the VLA alpha 6 subunit with a novel protein. A possible alternative to the common VLA beta 1 subunit on certain cell lines. Journal of Biological Chemistry 264(11): 6529-6535, 1989

Hodgkins cell lines immunologically incompatible with any defined hematopoietic cell type. Clinical Research 33(2 Part 1): 384A, 1985

Profiling of Vascular Endothelial Growth Factor Receptor Heterogeneity Identifies Protein Expression-defined Subclasses of Human Non-small Cell Lung Carcinoma. Anticancer Research 36(7): 3277-3288, 2016

Heterogeneity of protein kinase C isoenzyme gene expression in human T cell lines. Protein kinase C-beta is not required for several T cell functions. Journal of Immunology 143(5): 1692-1695, 1989

Nuclear translocation of the regulatory subunit RIIapprxbeta and the catalytic subunit Capprxalpha of protein kinase A in apoptosis induced by protein kinase A RIapprxalpha antisense in prostate cancer cells. Molecular Biology of the Cell 11(Suppl.): 250a, 2000

Involvement of protein kinase C beta-extracellular signal-regulating kinase 1/2/p38 mitogen-activated protein kinase-heat shock protein 27 activation in hepatocellular carcinoma cell motility and invasion. Cancer Science 99(3): 486-496, 2008

The Jun kinase pathway promotes growth of prostate carcinoma cell lines. Cancer Gene Therapy 5(6 CONF Suppl. ): S31, 1998